Carvedilol treatment after myocardial infarct decreases cardiomyocytic apoptosis in the peri-infarct zone during cardioplegia-induced cardiac arrest

Shock

Volumn 39, Issue 4, 2013, Pages 343-352

  Yeh, Chi Hsiao ^a,b   Chen, Tzu Ping ^a   Wang, Yao Chang ^a   Lin, Yu Min ^b   Fang, Shu Wen ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

apoptosis; Carvedilol; hypoxia reoxygenation; myocardial infarction

Indexed keywords

CARVEDILOL; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYTOCHROME C; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PHOSPHATE BUFFERED SALINE; PHOSPHATIDYLINOSITOL 3 KINASE; PLACEBO; PROTEIN BCL 2; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DOSE RESPONSE; EX VIVO STUDY; GENE EXPRESSION; HEART ARREST; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IN VITRO STUDY; ISOLATED HEART; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; REPERFUSION INJURY; SHAM PROCEDURE; SIGNAL TRANSDUCTION;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CARBAZOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HEART ARREST, INDUCED; LIGATION; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; PROPANOLAMINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84875367672     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31828c588a     Document Type: Article

References (31)

1. Iwai-Kanai E, Hasegawa K, Araki M, Kakita T, Morimoto T, Sasayama S: α- And β-Adrenergic pathways differentially regulate cell type-specific apoptosis in rat cardiac myocytes. Circulation 100:305-311, 1999. (Pubitemid 29340139)
2. Coleman CI, Perkerson KA, Gillespie EL, Kluger J, Gallagher R, Horowitz S, White CM: Impact of prophylactic postoperative β-blockade on postcardiothoracic surgery length of stay and atrial fibrillation. Ann Pharmacother 38:2012-2016, 2004. (Pubitemid 40169367)
3. Wallace AW, Au S, Cason BA: Association of the pattern of use of perioperative β-blockade and postoperative mortality. Anesthesiology 113:794-805, 2010.
4. McGory ML, Maggard MA, Ko CY: A meta-analysis of perioperative beta blockade: what is the actual risk reduction? Surgery 138:171-179, 2005. (Pubitemid 41253798)
5. Frishman WH: Carvedilol. N Eng J Med 339:1759-1765, 1998.
6. Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, Lubsen J, Lutiger B, Metra M, Remme WJ, et al.: Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or METOPROLOL EUROPEAN TRIAL (COMET): randomised controlled trial. Lancet 362:7-13, 2003. (Pubitemid 36835815)
7. Yue TL, Cheng HY, Lysko PG, McKenna PJ, Feuerstein R, Gu JL, Lysko KA, Davis LL, Feuerstein G: Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger. J Pharmacol Exp Ther 263:92-98, 1992.
8. Yue TL, McKenna PJ, Lysko PG, Gu JL, Lysko KA, Ruffolo RR Jr, Feuerstein GZ: SB 211475, a metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidant. Eur J Pharmacol 251:237-243, 1994. (Pubitemid 24061099)
9. Rossig L, Haendeler J, Mallat Z, Hugel B, Freyssinet JM, Tedgui A, Dimmeler S, Zeiher AM: Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol. J Am Coll Cardiol 36:2081-2089, 2000.
10. Cinquegrana G, D'Aniello L, Landi M, Spinelli L, Grande G, De Prisco F, Petretta M: Effects of different degrees of sympathetic antagonism on cytokine network in patients with ischemic dilated cardiomyopathy. J Card Fail 11: 213-219, 2005. (Pubitemid 40462425)
11. Aruoma OI: Scavenging of hypochlorous acid by carvedilol and ebselen in vitro. Gen Pharmacol 28:269-272, 1997. (Pubitemid 27016137)
12. Yeh CH, Chen TP, Lee CH, Wu YC, Lin YM, Lin PJ: Cardioplegia-induced cardiac arrest under cardiopulmonary bypass decreased nitric oxide production which induced cardiomyocytic apoptosis via nuclear factor .B activation. Shock 27:422-428, 2007. (Pubitemid 46594975)
13. Yeh CH, Chen TP, Wu YC, Lin YM, Lin PJ: Inhibition of NF.B activation with curcumin attenuates plasma inflammatory cytokines surge and cardiomyocytic apoptosis following cardiac ischemia/reperfusion. J Surg Res 125:109-116, 2005.
14. Loor G, Schumacke PT: Role of hypoxia-inducible factor in cell survival during myocardial ischemia-reperfusion. Cell Death Differ 15:686-690, 2008. (Pubitemid 351405073)
15. Yeh CH, Chen TP, Wang YC, Lin YM, Fang SW: AMP-activated protein kinase activation during cardioplegia-induced hypoxia/reoxygenation injury attenuates cardiomyocytic apoptosis via reduction of endoplasmic reticulum stress. Mediat Inflamm 2010;2010:130636. Epub 2011 Jan 23.
16. Curran J, Hinton MJ, R?́os E, Bers DM, Shannon TR: β-Adrenergic enhancement of sarcoplasmic reticulum calcium leak in cardiac myocytes is mediated by calcium/calmodulin-dependent protein kinase. Circ Res 100:391-398, 2007.
17. Leblais V, Jo SH, Chakir K, Maltsev V, Zheng M, Crow MT, Wang W, Lakatta EG, Xiao RP: Phosphatidylinositol 3-kinase offsets cAMP-mediated positive inotropic effect via inhibiting Ca2+ influx in cardiomyocytes. Circ Res 95: 1183-1190, 2004. (Pubitemid 39648209)
18. Aikawa R, Komuro I, Yamazaki T, Zou Y, Kudoh S, Tanaka M, Shiojima I, Hiroi Y, Yazaki Y: Oxidative stress activates extracellular signal-regulated kinases through src and ras in cultured cardiac myocytes of neonatal rats. J Clin Invest 100:1813-1821, 1997. (Pubitemid 27431340)
19. Chen JW, Lin FY, Chen YH, Wu TC, Chen YL, Lin SJ: Carvedilol inhibits tumor necrosis factor-α-induced endothelial transcription factor activation, adhesion molecule expression, and adhesiveness to human mononuclear cells. Arterioscler Thromb Vasc Biol 24:2075-2081, 2004.
20. Wang R, Miura T, Harada N, Kametani R, Shibuya M, Fukagawa Y, Kawamura S, Ikeda Y, Hara M, Matsuzaki M: Pleiotropic effects of the betaadrenoceptor blocker carvedilol on calcium regulation during oxidative stressinduced apoptosis in cardiomyocytes. J Pharmacol Exp Ther 318:45-52, 2006.
21. Schwarz ER, Kersting PH, Reffelmann T, Meven DA, Al-Dashti R, Skobel EC, Klosterhalfen B, Hanrath P: Cardioprotection by carvedilol: antiapoptosis is independent of beta-adrenoceptor blockage in the rat heart. J Cardiovasc Pharmacol Ther 8:207-215, 2003. (Pubitemid 37158967)
22. Zhuang XF, Yin CQ, Wang HY, Sun NL: Distinctive effects of carvedilol in the non-infarct zone: remodelling of the ligated rat heart linked to oxidative stress. J Int Med Res 37:1354-1364, 2009.
23. Rehsia NS, Dhalla NS: Mechanisms of the beneficial effects of beta-adrenoceptor antagonists in congestive heart failure. Exp Clin Cardiol 15:e86-e95, 2010.
24. Hryniewicz K, Androne AS, Hudaihed A, Katz SD: Comparative effects of carvedilol and metoprolol on regional vascular responses to adrenergic stimuli in normal subjects and patients with chronic heart failure. Circulation 108: 971-976, 2003. (Pubitemid 37048227)
25. Intengan HD, Schiffrin EL: Disparate effects of carvedilol versus metoprolol treatment of stroke-prone spontaneously hypertensive rats on endothelial function of resistance arteries. J Cardiovasc Pharmacol 35:763-768, 2000. (Pubitemid 30253618)
26. Remme WJ, Torp-Pedersen C, Cleland JG, Poole-Wilson PA, Metra M, Komajda M, Swedberg K, Di Lenarda A, Spark P, Scherhag A, et al.: Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET. J Am Coll Cardiol 49:963-971, 2007. (Pubitemid 46335773)
27. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, Itescu S: Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7: 430-436, 2001. (Pubitemid 32298545)
28. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw BA: Apoptosis in myocytes in end-stage heart failure. N Engl J Med 335:1182-1189, 1996. (Pubitemid 26339772)
29. Kurz T, Richardt D, Gorge B, Hartmann F, Tölg R, Katus HA, Richardt G: Differential effects of carvedilol on norepinephrine release in normoxic and ischemic heart. J Cardiovasc Pharmacol 36:96-100, 2000. (Pubitemid 30419128)
30. Xiao RP, Zhu W, Zheng M, Chakir K, Bond R, Lakatta EG, Cheng H: Subtypespecific β-adrenoceptor signaling pathways in the heart and their potential clinical implications. Trends Pharmacol Sci 25:358-365, 2004. (Pubitemid 38829489)
31. Noma T, Lemaire A, Naga Prasad SV, Barki-Harrington L, Tilley DG, Chen J, Le Corvoisier P, Violin JD, Wei H, Lefkowitz RJ, et al.: β-Arrestin- mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection. J Clin Invest 117:2445-2458, 2007.